Veradigm Product Portfolio Achieves HITRUST i1 Certification
Veradigm Product Portfolio Achieves HITRUST i1 Certification
Independent validation confirms rigorous, continuously assessed security controls protecting sensitive healthcare data across a broad set of Veradigm solutions
Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data, clinical, and revenue cycle solutions, today announced that a broad set of its solutions has achieved HITRUST i1 Certification. The certification provides validated assurance that the security controls protecting these systems have been independently assessed and centrally reviewed through the HITRUST Assurance Program. “This certification validates the strength and discipline of the cybersecurity program we’ve built and maintained for years. It gives our clients and prospective clients confidence that the rigor behind our security practices meets the industry’s highest bar,” said Tehsin Syed, Chief Product and Technology Officer of Veradigm.
About the HITRUST i1 Certification
The HITRUST i1 Certification is a threshold-based assessment built around leading security practices and designed to demonstrate real cyber resilience, not just policy on paper. It evaluates a curated set of controls chosen to address current and evolving threats. Earning it requires an organization to prove that those controls are implemented and working, verified through independent assessment rather than self-attestation.
Why It Matters
HITRUST i1 Certification gives customers and partners a standardized, independently validated assurance signal for the certified solutions. That means less uncertainty and more efficient security reviews, backed by one of the most widely recognized frameworks in healthcare.
Veradigm plans to continue investing in its security and compliance program, building on a long track record of protecting the sensitive healthcare data its clients and partners rely on every day.
Solutions that have earned HITRUST i1 Certification include:
- Veradigm EHR
- Veradigm Practice Management
- Practice Fusion
- Veradigm ePrescribe
- Payerpath
- FollowMyHealth
- Transaction Hub
- Veradigm Compliance Reporting Solution
- Veradigm eChart Courier (eCC)
- Veradigm eChart Integration and Analytics
- Veradigm eChart Coder
- Veradigm Payer Insights
- Veradigm Comprehensive Submissions
- Veradigm Risk Adjustment Analytics and Risk Mitigator
- Veradigm Quality Analytics
- Veradigm Collaborate
About HITRUST
HITRUST provides cybersecurity assurance through the HITRUST CSF® and the HITRUST Assurance Program™, helping organizations produce evidence that stakeholders can rely on with confidence. HITRUST reports that 99.62% of HITRUST-certified environments were breach-free in 2025. (Source: HITRUST 2026 Trust Report)
Report Availability and Verification
Validated results are shared through the HITRUST Report Center and can be requested through Veradigm’s dashboard at reportcenter.mycsf.net.
About Veradigm®
Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system.
© 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.
Veradigm Contacts:
Investors:
Steven Halper
312-506-1237
steven.halper@veradigm.com
Media:
Katie Wilson
601-398-7000
katie.wilson@veradigm.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20261021077591/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
3 of the Best Dividend Stocks to Own
The 10 Best Companies to Invest in Now
This Once-Hot AI Stock Now Looks Deeply Undervalued